SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
To explore the beneficial effects of \'empagliflozin + ARB\' in comparison with \'placebo + ARB\' on the reduction of nocturnal blood pressure in T2DM with hypertension
Epistemonikos ID: 60aedd5e67ff4fbd05e9b4f06b5b381fb0a56856
First added on: May 20, 2024